Mass Torts Update - Written by Beasley Allen on Tuesday, March 13, 2012 15:35 - 0 Comments

New NuvaRing Lawsuit Filed

A recently filed NuvaRing blames the contraceptive for a woman’s DVT, also known as deep vein thrombosis. The , seeking damages, is one of many NuvaRing lawsuits that have been filed. Dawn Kregel, of Denton, Texas, filed the in a Texas court against NuvaRing makers Organon USA Inc., Organon Pharmaceuticals USA Inc., Organon International Inc., Schering-Plough Corp., and Merck & Co. Inc. Ms. Kregel alleges that she suffered a DVT shortly after using the device.

Ms. Kregel used the monthly device for a little over one month in 2010 and she was subsequently diagnosed with a DVT. It’s alleged that the DVT was caused by the NuvaRing device. The was filed in the Eastern District of Texas, Sherman Division. NuvaRing is a transparent, flexible vaginal ring that provides month-long by emitting a continuous dose of estrogen and progestin for 21 days. The device releases a combination of ethinyl estradiol, a form of the hormone estrogen, and etonogestral. NuvaRing is marketed as providing the same efficacy as pills, but with the convenience of month-long protection.

Ms. Kregel contends that the Defendants neglected to warn that NuvaRing was linked to more thrombotic events than the pill. The Defendants were accused of marketing, promoting, and advertising NuvaRing as having a relatively low level of estrogen in order to mask the fact that it had a high level of dangerous third-generation progestin. Ms. Kregel, had she been aware of the increased risks connected to NuvaRing, would have used a different form of .

Other NuvaRing lawsuits claim the device caused the sudden deaths of users. An FDA study, published on October 2011, found that the NuvaRing was associated with a significantly higher risk of deep vein thrombosis and pulmonary embolism relative to standard low-dose estrogen pills. The study also mentioned that continuous exposure to combined hormonal contraceptives such as the NuvaRing “potentially result in higher sustained exposure to estrogen and hence, increased thromboembolic risk. According to the Mayo Clinic, side effects of NuvaRing may include: Vaginal infection or irritation; Vaginal secretion; Increased risk of blood-clotting problems, heart attack, stroke, liver cancer, gallbladder disease and high blood pressure; fluid retention; breakthrough bleeding or spotting; weight gain; headache; depression; nausea; breast tenderness; and decreased sex drive.

It’s alleged in the NuvaRing lawsuits that, because the device delivers a constant stream of hormone unmediated by the digestive system or the liver, patients end up receiving higher doses than they do from older pills. High estrogen doses create a greater risk of blood clots, which can be fatal. Hundreds of NuvaRing lawsuits, similar to the one filed by Ms. Kregel, are currently pending in a multidistrict in U.S. District Court, Eastern District of Missouri.

Sources: PRWeb.com and The Southeast Texas Record



Leave a Reply

Comment

Comments are moderated and generally will be posted if they are on-topic and not abusive.

Powered by WP Hashcash

Recent Settlements - Feb 9, 2012 7:09 - 0 Comments

Settlement In BTSI Defect Case

More In Recent Settlements


Product Liability - Dec 2, 2014 11:54 - 0 Comments

Korean Automakers Hyundai And Kia Agree To Record U.S. Settlement For Mileage Fraud

More In Product Liability


Recalls Update - Dec 1, 2014 14:39 - 0 Comments

Andrew Brashier

More In Recalls Update